Risperidone medication errors in children: an analysis of French poison centres data - Vial T, Patat AM, Paret N, Boels D, Torrents R, Nisse P, Villa A, Kassai B.
OBJECTIVES: To describe clinical consequences of risperidone medication errors in children of less than 13 years and to estimate a clinically relevant toxic dose. METHODS: All cases of risperidone medication errors managed by French Poison Centres ... (Source: SafetyLit)
Source: SafetyLit - November 21, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
'Robbed of precious time': chemical restraints and aged care | Sarah Russell
Nearly two-thirds of aged care residents are prescribed psychotropic drugs regularly. Questions that must be urgently askedThis is part of a series about aged care in AustraliaMary ’s 85-year-old husband had been in an aged care home for just over a week. He had been getting frailer but was still sharp mentally. However, Mary* became extremely worried when her husband started sleeping all day.After much ado, Mary obtained access to the medication chart for her husband. The aged care home ’s GP had prescribed risperidone (an anti-psychotic medication), oxazepan (a benzodiazepine that is highly addictive and causes sedat...
Source: Guardian Unlimited Science - September 13, 2018 Category: Science Authors: Sarah Russell Tags: Ageing Science Society Source Type: news
Perseris (Risperidone) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 22, 2018 Category: Drugs & Pharmacology Source Type: news
FDA OKs Once-Monthly Risperidone Injection for Schizophrenia FDA OKs Once-Monthly Risperidone Injection for Schizophrenia
Clinically relevant levels of the antipsychotic are reached after the first injection without use of a loading dose or any supplemental oral risperidone.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news
FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
SLOUGH, England and RICHMOND, Va., July 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved Perseris, the first once-monthly subcutaneous risperidone-containing, long-acting... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 27, 2018 Category: Drugs & Pharmacology Source Type: news
Aggression following traumatic brain injury: effectiveness of risperidone (AFTER): study protocol for a feasibility randomised controlled trial - Deb S, Leeson V, Aimola L, Bodani M, Li L, Weaver T, Sharp D, Crawford M.
BACKGROUND: Traumatic brain injury (TBI) is a major public health concern and many people develop long-lasting physical and neuropsychiatric consequences following a TBI. Despite the emphasis on physical rehabilitation, it is the emotional and behavioural ... (Source: SafetyLit)
Source: SafetyLit - July 2, 2018 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co-occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI.
To evaluate the effects of risperidone compared to treatment with other antipsychotics (first-generation and other second-generation antipsychotics) used in people with serious mental illness and co-occurring substance misuse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 25, 2018 Category: Consumer Health News Source Type: news
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) - Ostinelli EG, Hussein M, Ahmed U, Rehman FU, Miramontes K, Adams CE.
BACKGROUND: Aggressive, agitated or violent behaviour due to psychosis constitutes an emergency psychiatric treatment where fast-acting interventions are required. Risperidone is a widely accessible antipsychotic that can be used to manage psychosis-induce... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news
Risperdal (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 12, 2018 Category: Drugs & Pharmacology Source Type: news
Lowering Antipsychotic Dose Can Improve Symptoms in Schizophrenia Lowering Antipsychotic Dose Can Improve Symptoms in Schizophrenia
Reducing the dose of risperidone and olanzapine can improve cognitive function and negative symptoms in patients with stable schizophrenia, new research from China suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Add-on Antipsychotic Promising for PTSD, Anxiety Add-on Antipsychotic Promising for PTSD, Anxiety
Patients with posttraumatic stress disorder (PTSD) who are being treated with antidepressants may experience additional symptom improvement with adjunctive risperidone, a new meta-analysis suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 5, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Comparing resource use and costs in Taiwan: LAI vs oral risperidone
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2018 Category: Drugs & Pharmacology Source Type: news
Clinical implications from the Treatment of Severe Childhood Aggression (TOSCA) study: a re-analysis and integration of findings - Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG.
This article summarizes the clinical implications; reanalyzes the... (Source: SafetyLit)
Source: SafetyLit - November 30, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Risperdal Consta (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2017 Category: Drugs & Pharmacology Source Type: news
Placebo Might Be Superior to Antipsychotics for Delirium Placebo Might Be Superior to Antipsychotics for Delirium
Is risperidone or haloperidol effective for dementia in patients receiving palliative care?Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2017 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news
